In 2017, the Indiana General Assembly passed legislation requiring the Indiana State Department of Health (ISDH) to establish a registry of individuals who have been diagnosed by a neurologist as having treatment-resistant epilepsy. The law provides individuals on the registry with defenses to prosecution of the crime of possession of a substance containing cannabidiol and allegations of certain conditions found in IC 16-42-28.6-10. In order to qualify for the registry, individuals must:
- Be a patient or caregiver;
- Provide proof of Indiana residency;
- Provide a certified statement by an Indiana-licensed physician certified in neurology that the patient or a patient in the care of the caregiver has been examined and diagnosed by the physician to have treatment-resistant epilepsy;
-“Treatment-resistant epilepsy" means:
- Dravet syndrome;
- Lennox-Gastaut syndrome;
- Another form of epilepsy in a patient who has not responded to at least two of the epilepsy treatment options that have been provided in good faith.
- Complete application, which will be provided by the ISDH; and
- Pay a $50 registration fee in accordance with IC 16-42-28.6-7.
A fillable registration form can be downloaded here.
Completed registration packets can be mailed, along with payment, to:
Indiana State Department of Health
Chronic Disease, Primary Care, and Rural Health
Attn: Cannabidiol Registry
2 N. Meridian St., 6B
Indianapolis, IN 46204
Individuals who wish to pay by credit card can do so here.
Please note that all credit card payments will incur a processing fee of $1 plus 2 percent of the total.
Registrants can expect to receive a card confirming registration within two weeks after ISDH receives a completed packet and payment.
If you have questions about the registration process, call (844) 624-6667 or email email@example.com.